
Insmed (NASDAQ:INSM) brought in sales totaling $56.12 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 0.23%, resulting in a loss of $112.98 million. Insmed collected $46.76 million in revenue during Q3, but reported earnings showed a $112.71 million loss.